Date Filed | Type | Description |
06/02/2023 |
4
| Ciaffoni Joseph (President and CEO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns:
| Sold 31,272 shares
@ $22.0887, valued at
$690.8k
Sold 30,272 shares
@ $21.5768, valued at
$653.2k
Sold 1,000 shares
@ $22.2511, valued at
$22.3k
|
|
06/01/2023 |
4
| Ciaffoni Joseph (President and CEO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns:
| Sold 31,271 shares
@ $21.9023, valued at
$684.9k
Sold 31,272 shares
@ $21.8661, valued at
$683.8k
|
|
02/14/2023 |
4
| Ciaffoni Joseph (President and CEO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns:
| Granted 117,500 shares
@ $0 Granted 137,694 shares
@ $0 Paid exercise price by delivering 44,121 shares
@ $26.75, valued at
$1.2M
Paid exercise price by delivering 59,736 shares
@ $26.75, valued at
$1.6M
Sold 11,250 shares
@ $26.88, valued at
$302.4k
Exercised 11,250 options to buy
@ $15.9, valued at
$178.9k
|
|
12/21/2022 |
4
| Ciaffoni Joseph (President and CEO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns:
| Sold 1,134 shares
@ $23.01, valued at
$26.1k
Sold 9,375 shares
@ $23.07, valued at
$216.3k
Sold 7,333 shares
@ $23.11, valued at
$169.5k
|
|
12/05/2022 |
4
| Ciaffoni Joseph (President and CEO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns:
| Sold 76,653 shares
@ $22.47, valued at
$1.7M
Sold 54,400 shares
@ $23.07, valued at
$1.3M
Exercised 76,653 options to buy
@ $15.9, valued at
$1.2M
|
|
11/30/2022 |
4
| Ciaffoni Joseph (President and CEO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns:
| Sold 43 shares
@ $22, valued at
$946 Exercised 43 options to buy
@ $15.9, valued at
$683.7 |
|
11/25/2022 |
4
| Ciaffoni Joseph (President and CEO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns:
| Sold 65 shares
@ $22, valued at
$1.4k
Exercised 65 options to buy
@ $15.9, valued at
$1k
|
|
11/22/2022 |
4
| Ciaffoni Joseph (President and CEO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns:
| Sold 1,989 shares
@ $22.02, valued at
$43.8k
Exercised 1,989 options to buy
@ $15.9, valued at
$31.6k
|
|
07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/14/2022 |
4
| Ciaffoni Joseph (President and CEO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns:
| Granted 125,000 shares
@ $0 Granted 65,034 shares
@ $0 Paid exercise price by delivering 24,154 shares
@ $17.63, valued at
$425.8k
Paid exercise price by delivering 28,843 shares
@ $17.63, valued at
$508.5k
|
|
01/05/2022 |
4
| Ciaffoni Joseph (President and CEO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns:
| Paid exercise price by delivering 1,090 shares
@ $18.68, valued at
$20.4k
|
|
08/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/22/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
01/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2020 |
4
| Ciaffoni Joseph (President and CEO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns:
| Paid exercise price by delivering 4,672 shares
@ $21.24, valued at
$99.2k
Sold 70,576 shares
@ $21.53, valued at
$1.5M
Sold 100 shares
@ $22.08, valued at
$2.2k
Sold 5,761 shares
@ $20.47, valued at
$117.9k
Sold 100 shares
@ $21.3, valued at
$2.1k
Exercised 64,820 options to buy
@ $8.22, valued at
$532.8k
|
|
02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/02/2019 |
4
| Ciaffoni Joseph (President and CEO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns:
| Paid exercise price by delivering 4,678 shares
@ $21.73, valued at
$101.7k
|
|
11/08/2019 |
4
| Ciaffoni Joseph (President and CEO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns:
| Sold 33,595 shares
@ $18.41, valued at
$618.5k
Sold 31,226 shares
@ $19.16, valued at
$598.3k
Exercised 64,821 options to buy
@ $8.22, valued at
$532.8k
|
|
08/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/04/2019 |
4
| Ciaffoni Joseph (President and CEO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns:
| Sold 5,851 shares
@ $11.52, valued at
$67.4k
Paid exercise price by delivering 3,097 shares
@ $11.51, valued at
$35.6k
Sold 7,436 shares
@ $11.59, valued at
$86.2k
|
|
02/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|